Dr. Roland Kurrle

Dr. Kurrle is the founder of ImmbiCon, where he is focused on giving scientific advice for research and development projects in the field of immunology, immunotherapeutics and development of biotherapeutics. For more than 30 years he has worked as an executive R & D scientist and manager for major pharmaceutical companies in Germany and USA, like Behringwerke AG, Marburg, Hoechst Marion Roussel Wiesbaden / Frankfurt, Aventis Frankfurt / Bridgewater (New Jersey), and Sanofi-Aventis Bridgewater (New Jersey)/ Frankfurt.

His responsibilities diversified,  and he also supervises joint discovery and development programs, many in long-time collaborations with renowned biotech- or pharmaceutical companies, e.g. Immunex (now Amgen), Vertex, Millennium (now Takeda), Coley (now Pfizer), Integrated Genetics (now Genzyme / Sanofi), Toyobo and Pfizer.

Dr. Kurrle is the author / co-author of > 100 publications, inventor / co-inventor of >15 patent applications and is a member of several academic societies, e.g. the German Society of Immunology (since 1976).